The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
Official Title: A Pivotal Study to Evaluate the Safety and Effectiveness of Exablate Model 4000 Using Microbubble Resonators to Temporarily Mediate Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
Study ID: NCT05383872
Brief Summary: The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier disruption with Exablate Model 4000 Type 2.0/2.1 for liquid biopsy in subjects with suspected Glioblastoma brain tumors
Detailed Description: This is a prospective, multi-center, pivotal clinical trial to evaluate the safety and efficacy of targeted blood brain barrier disruption using Exablate Model 4000 Type 2 for liquid biopsy in subjects with suspected Glioblastoma brain tumors. The study will be conducted at up to 25 centers in the US.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
University of California, Los Angeles, Los Angeles, California, United States
University of California San Francisco, San Francisco, California, United States
UF Health Shands Hospital, Gainesville, Florida, United States
Miami Cancer Institute at Baptist Health, Miami, Florida, United States
Tampa General Hospital, Tampa, Florida, United States
University of Maryland, Baltimore & The University of Maryland Medical System, Baltimore, Maryland, United States
Johns Hopkins University, Baltimore, Maryland, United States
Mayo Clinic, Rochester, Minnesota, United States
NYU Grossman School of Medicine, New York, New York, United States
Duke University, Durham, North Carolina, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
University of Texas, Southwestern, Dallas, Texas, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
West Virginia University Rockefeller Neuroscience Center, Morgantown, West Virginia, United States
Sunnybrook Research Institute, Toronto, Ontario, Canada